Consolidated Statements of Operations (USD $)	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Product sales	$ 1,213,417	$ 1,327,127
Cost of product sales	1,147,075	1,111,527
Gross income	66,342	215,600
Operating expenses:
Research and development expenses	251,314	114,522
Research and development reimbursement	(50,000)
Sales and marketing expenses	314,418	373,425
General and administrative expenses	652,927	596,133
Total operating expenses	1,168,659	1,084,080
Operating loss	(1,102,317)	(868,480)
Non-operating income (expense):
Interest income	187	1,061
Financing and interest expense	(94)	(4,463)
Non-operating (expense) income, net	93	(3,402)
Net loss	(1,102,224)	(871,882)
Preferred stock dividends	(2,658)	(2,658)
Net loss applicable to common shareholders	$ (1,104,882)	$ (874,540)
Basic and diluted loss per share	$ (0.04)	$ (0.04)
Weighted average shares used in computing net loss per share:
Basic and diluted	26,487,140	23,048,754